N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-(difluoromethyl)-4-methylfuran-3-carboxamide
C18H10ClF4N3O4 — CID 90394515
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-(difluoromethyl)-4-methylfuran-3-carboxamide
N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-(difluoromethyl)-4-methylfuran-3-carboxamide (PubChem CID 90394515) has the molecular formula C18H10ClF4N3O4 and a molecular weight of 443.74 g/mol. Its IUPAC name is N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-(difluoromethyl)-4-methylfuran-3-carboxamide.
Molecular Properties
| Compound Name | N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-(difluoromethyl)-4-methylfuran-3-carboxamide |
|---|---|
| PubChem CID | 90394515 |
| Molecular Formula | C18H10ClF4N3O4 |
| Molecular Weight | 443.74 g/mol |
| Exact Mass | 443.03 |
| IUPAC Name | N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-(difluoromethyl)-4-methylfuran-3-carboxamide |
| SMILES | Cc1coc(C(F)F)c1C(=O)Nc1cnc(-c2cc3c(cc2Cl)OC(F)(F)O3)cn1 |
| InChI | InChI=1S/C18H10ClF4N3O4/c1-7-6-28-15(16(20)21)14(7)17(27)26-13-5-24-10(4-25-13)8-2-11-12(3-9(8)19)30-18(22,23)29-11/h2-6,16H,1H3,(H,25,26,27) |
| InChIKey | GAGAHJLCMJPEQJ-UHFFFAOYSA-N |
| XLogP | 5.21 |
| TPSA | 86.48 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 443.74 |
| LogP ≤ 5 | 5.21 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90394515 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.